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http://dx.doi.org/10.1016/j.pedneo.2Aim: To determine whether the “Oxygen with Love” (OWL) and diode laser treatment provided
in a neonatal intensive care unit has reduced the risk of avoidable blindness caused by retinop-
athy of prematurity (ROP) over the past decade.
Materials and methods: A prospective observational cohort study was performed, in which 351
infants were examined for ROP. The inclusion conditions were as follows: preterm infants,
birthweight <1500 g or <32 weeks’ gestational age, and birth between 1 Jan 2000 to 31 August
2012. From mid-2009, the OWL program was implemented and the ventilation protocols for
such infants were amended. We tested whether the incidence of unfavorable structural out-
comes of ROP had decreased following these changes.
Results: From 2004 to 2012, the survival rates of younger children increased (p < 0.003). From
2005 to 2012, laser treatment rather than cryotherapy was applied, and the incidence of un-
favorable structural outcomes of ROP fell from 13% to 5.6% (not significant). From 2009 to
2012, the incidence of ROP decreased from 55% to 29% (p < 0.002). From 1 August 2009 toista Miguel Montalvo Jime´nez, 6 C.P 18014, Granada, Spain.
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ablative treatment of the retina
treatment.
Period
2000e2003
2004 to July 2009
August 2009 to 201231 August 2012, there was less need for ablative treatment for premature infants, with the
rate falling from 11.81% to 3.9% (p < 0.03). This improvement was significantly associated with
a reduction in the number of days of intubation (p < 0.0017), lower rates of sepsis (p < 0.003),
and improvements in postnatal weight gain (p < 0.0002).
Conclusion: The introduction of the OWL program, together with lower rates of sepsis, im-
provements in postnatal weight gain, and the use of diode laser treatment, has reduced the
incidence of unfavorable structural outcomes of ROP.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Retinopathy of prematurity (ROP) and cortical blindness are
the most common causes of blindness in premature in-
fants.1 To minimize the rate of avoidable blindness due to
ROP, two possible courses of action may be taken:
continuing improvements in neonatal care, to reduce the
incidence of infants with ROP and treatable severe ROP2e4;
and, with respect to the ophthalmologist, the detection of
all treatable cases and continuing improvements in tech-
niques and modes of treatment.5e8
The present study aimed to determine whether the
modifications introduced in our neonatal intensive care unit
(NICU) have achieved objective improvements in the care
and treatment of ROP, and if so, which variables are of most
influence.
2. Materials and Methods
We studied 351 newborn infants included in the retinopathy
examination protocol for premature infants at San Cecilio
University Hospital (Granada, Spain) over a study period from
January, 2000 until August 31, 2012. The inclusion conditions
wereas follows:preterminfantsofbirthweight<1500gor<32
weeks’ gestational age, and birth between 2000 and 2012.
The following variables were included in the study:
gestational age at birth, birthweight, peak ROP stage for
each newborn, the need for treatment, the structural
outcome of treatment, and the type of treatment usedd
cryotherapy (2000e2004) or laser (2005e2012). The change
of treatment criterion was made (from CRYO-ROP to ET-
ROP) in 2004. Comorbidity was defined as any event,
complication, or treatment that is not expected in a child
born healthy in a natural childbirth. The following variables
were used to assess comorbidity: the presence of sepsis,
the stage of hyaline membrane disease, persistent ductus
arteriosus, the number of days of intubation, the degree ofhy of prematurity program in t
and the number presenting a
n Trea
Cryotherapy
105 11
148 4
97 0cerebral hemorrhage, the need for blood transfusion, ce-
sarean section, surfactant therapy, maternal hypertension,
the need for exchange transfusion, and extracranial bypass
surgery. A point was assigned to quantify the comorbidity of
each of these events, and the sum of the scores for each of
the variables gave the total comorbidity score for each
premature infant.
Table 1 shows the distribution of patients in this study.
The same ophthalmologist was responsible for eye exami-
nations from 2000 to 2012. Staging of ROP was based on
retinal examination prior to discharge, with severe ROP
stage 0 Z no ROP, ROP incidence Z ROP stage > 1, ROP >
2 Z progression ROP, severe ROP defined as stages 3e5.9
The eye was classified as having an unfavorable outcome
in ROP if at least one of the following findings was present:
a retinal fold involving the macula, a retinal detachment
involving zone I of the posterior pole, and retrolental tis-
sue, or a “mass.”10
In order to distribute the number of newborn infants
evenly within the study interval, the sample was divided
into three time periods: 2000e2003, 2004e2008, and
2009e2012. From August 2009 to 2012, a series of organi-
zational changes were introduced, including the wide-
spread application of “Oxygen with Love” (OWL)11e13 and
the use of ventilation volume guarantee level techniques
and noninvasive ventilation,14,15 raising awareness among
the staff of the neonatal unit of the need for newborns to
gain at least 7 g of body weight per day during the first
month of life.16 This was accompanied by improvements in
clinical practice to reduce the risk of sepsis and the number
of transfusions needed.17,18
As part of the OWL program, intended for pediatricians,
nurses, and respiratory therapists, the oxygen management
policy of the NICU was revised as follows: for very low
birthweight (VLBW) infants, oxygen saturation (SpO2) target
range of 85e93% from birth to 36 weeks’ postmenstrual
age, a standardized bedside oximeter alarm setting for all
VLBW infants, and guidelines for managing low and highhree time periods, showing the number of infants requiring
n unfavorable structural outcome, by cryotherapy or laser
tment Unfavorable outcome
Laser Cryotherapy Laser
0 1 0
15 1 1
4 0 0
Table 2 Mean values for weight, gestational age, retinopathy of prematurity, and associated comorbidity, together with the
rate of unfavorable structural outcomes.
2000e2003 2004e2008 2009e2012
Gestational age (wk) 30.4 29.6** 29.59**
Weight (g) 1410 1241** 1240***
Comorbidity 4.5 5.3** 4.86
ROP 2 29/105 (28%) 46/130 (35%) 16/115 (14%)***
ROP 1 52/105 (49%) 71/130 (55%) 30/115 (26.1%)***
Unfavorable structural outcomes 1/11 (9%) 2/14 (14%) 0/9 (0%)
*p < 0.05, ** p < 0.01, ***p < 0.001.
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for oxygen prescribers (MDs and nurses) and bedside oxygen
providers (nurses and respiratory therapists). The session
focused on oxygen toxicities in premature infants and de-
tails of the new oxygen policy in the NICU. Policy compli-
ance checks included VLBW oximeter alarm limit audits
three times per day and continuous oximeter downloads to
assess achievement of the SpO2 goals.
Statistical analysis was performed using SPSS version
15.0 (SPSS Inc., Chicago, IL, USA). The statistical mean and
standard deviation (SD) were obtained for each factor, and
these values were compared for each of the three time
periods. The Student t test was applied to compare the
means, and the Chi-square test was used to compare the
qualitative variables.
3. Results
The sample consisted of 351 children identified by screening
for ROP in the periods from January 1, 2000 until December
31, 2003 (nZ 105), fromJanuary 1, 2004 until July 31, 2009 (n
Z 148) and August 1, 2009 until August 31, 2012 (nZ 98).Table 3 The retinopathy of prematurity program: results obt
(fewer days of intubation, a higher 5-minute Apgar score, a lowe
gain).
Janu
Intubation days (mean, SD) 8.14
Days of oxygen supplementation (mean, SD) 33.1
Apgar score at 1 minute (median, SD) 6
Apgar score at 5 minutes (median, SD) 7
Blood transfusions, n (%)
Not performed 127
Present 126
Sepsis, n (%)
Absent 161
Present 92
Cesarean, n (%)
Not performed 81
Performed 172
Weight gain 7 g/d
Absent 68
Present 185
*p < 0.05, **p < 0.01, ***p < 0.001.
SD Z standard deviation.Table 2 shows the data for the descriptive variables of
the newborns for each study interval. In 2000e2003, the
infants were more mature, with greater gestational ages
and higher birthweights than those born in the following
study periods. These findings explain the significant in-
crease in comorbidity of newborns in the later intervals
(tZ 2.61, pZ 0.0096). Of note is the finding that, despite
the increased comorbidity in 2004e2008 compared with the
period 2000e2003 (t Z 3.22, p Z 0.0014), there was no
significant increase in the incidence of ROP.
From 2009 to 2012, a series of organizational changes
were introduced, including the widespread application of
the OWL program (on best practice in oxygen use in hos-
pitals),12,13 raising awareness among neonatal staff of the
need for newborns to gain at least 7 g body weight per day
during the first month of life16 and to achieve improve-
ments in clinical practice to reduce the risk of sepsis and
the number of transfusions needed.17,18 We observed
Pearson correlation coefficients of 0.21 (p < 0.001) and
0.23 (p < 0.001), respectively, between the number of
sepsis events and the number of transfusions versus the
development of retinopathy.ained following the improvements made since August 2009
r rate of nosocomial sepsis, and increased postnatal weight
ary 2000eJuly 2009 August 2009eAugust 2012
(11.88) 3.56 (8.55)**
(63) 30.2 (31)
(2.46) 6 (2.27)
(2.49) 8 (1.66)*
(50.2) 54 (66)
(49.8) 43 (44)
(64) 74 (76)*
(36) 23 (24)
(32) 16 (21)
(68) 61 (79)
(27) 6 (6.2)***
(73) 91 (93.8)
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morbidity compared to the previous period (t Z 1.36,
p Z 0.09) in preterm infants with a similar gestational age
and birthweight. However, the changes in the management
of these children led to a statistically significant reduction
in the incidence of ROP  1 [c2 Z 19.3, p Z 0.0001, odds
ratio (OR)Z 0.29, 95% confidence interval (CI) 0.16e0.52],
and its progression ROP  2 (c2 Z 13.8, p Z 0.0002,
OR Z 0.3, 95% CI 0.15e0.58). We have no data on the in-
fants’ caloric intake prior to 2009, but from 2009 onward
we observed an average caloric intake in the first 14 days of
life of 1204 kcal (SD 157 kcal) in infants without retinop-
athy, and of 1365 kcal (SD 188 kcal) in those who developed
retinopathy, with no significant differences between the
groups. We observed a correlation coefficient of 0.30
(p < 0.001) between the degree of retinopathy and a
weight gain of greater than 7 g per day.
Regarding ablative treatment for ROP, 2 of 15 of the out-
comes were adverse in premature infants with threshold ROP
given cryotherapy. When laser treatment was applied for
prethreshold and threshold ROP, only 1 of 19 of outcomeswas
adverse. Inour sample, the treatmentoutcomesdidnotdiffer
significantly between cryotherapy and laser treatment.
From January 1 of 2000 until July 31, 2009, 30 of the 253
children included in theROPprogramat our hospital required
treatment. From August 2009 to February 2012, 97 children
were included in the same program, and only four required
treatment. The risk of retinopathy was significantly lower
during this latter period, anda significantly lowerpercentage
of children needed retinal ablation treatment (c2 Z 3.94,
pZ 0.02, ORZ 0.32, 95% CI 0.11e0.95).
On comparing the periods 2000 to July 2009 and August
2009 to February 2012, we observed a lower percentage of
sepsis (c2Z 4.53, pZ 0.03, ORZ 0.54, 95% CI 0.31e0.96),
fewer days of intubation [t Z 4.0, p < 0.001, degrees of
freedom (df) 241], a higher 5-minute Apgar score (tZ 2.54,
p Z 0.01, df 260), and a higher percentage of premature
infants gaining 7 g/day at 4e6 weeks of age (c2 Z 16.8,
p < 0.0001, OR Z 0.18, 95% CI 0.006e0.44) during the
latter period (Table 3).
With respect to unfavorable structural outcomes, the
following calculations were carried out, for the three study
periods (see Table 1): % infants presenting unfavorable
structural outcomeZ (% premature infants needing retinal
ablation)  (% unfavorable structural outcomes after
cryotherapy or laser treatment).(A) Period 2000e2003:
AZ10:48% ðretinal ablationÞ  13:3% ðcryotherapyÞZ1:4%(B) Period 2004 to July 2009:
B1Z12:84% ðretinal ablationÞ
 13:3% ðcryotherapyÞZ 1:71%B2Z 12:84% ðretinal ablationÞ  5:26% ðlaserÞZ 0:68%
(C) Period August 2009 to August 2012:
CZ 4:12% ðretinal ablationÞ  5:26% ðlaserÞZ 0:22%The relative risk of an unfavorable structural outcome
thus was calculated as: (1.4 e 0.22/1.4) Z 84.28%.
In summary, the relative risk of an unfavorable struc-
tural outcome for ROP was 84% lower in the final period
(August 2009 to August 2012) than in the first one
(2000e2003), due to the lower number of premature in-
fants requiring treatment and because outcomes improved
with the use of diode laser treatment.4. Discussion
During the period 2000e2003, infants with a greater birth-
weight and higher gestational age than in subsequent years
were included in the ROP program. As the inclusion criteria
remained unchanged during these years, we conclude that
survival rates improved in the subsequent periods of
2004e2008 and 2009e2012. This increase in the survival of
infants of less than 28 weeks’ gestation is also found in other
time series studies of ROP outcomes over 9e10 years.19,20
Since 2004, our study sample has reflected a reduction in
the mortality rates of preterm infants admitted to the
hospital. Those enrolled in the ROP protocol from 2004 to
2012 were more immature and presented with greater co-
morbidity, but despite this the incidence of ROP did not
increase. In 2005, diode laser treatment for ROP was
introduced, and this technique has reduced the rate of poor
outcomes, although the difference with respect to cryo-
therapy is not statistically significant. From 2009, the co-
morbidity rates of premature infants fell, as did the rate of
sepsis and the number of days of intubation required,
whereas the rate of postnatal weight gain increased. These
improvements in clinical practice produced a significant
reduction in the incidence of ROP and in the number of
infants with severe ROP treatable by retinal ablation.
Corroborating our results, Hellstro¨m et al21 related poor
weight gain during the first weeks of life with an increased
risk of retinopathy. These authors observed an association
between the increased risk of retinopathy and a birth-
weight below the 25th percentile, and with subsequent poor
weight gain. Stahl et al22 reported pathophysiologic infor-
mation relating deficient postnatal nutrition and low weight
gain to more prolonged retinal vascularization and poorer
visual outcome.
The strict control of oxygen saturation and supplemen-
tation in recent years has reduced the incidence of ROP in
children screened for the disease to 15e30%.8,10,23,24 From
2009 to 2012, the implementation of the OWL program in
our NICU significantly reduced the number of days of intu-
bation required and the rates of sepsis, and was also
associated with higher numbers of infants with adequate
postnatal gain and an increased 5-minute Apgar score.
However, another study concluded that advances in ob-
stetric and neonatal care were responsible for reducing the
incidence of severe ROP.25
In some ROP series, early treatment of prethreshold ROP
in zone I has been implemented.7 Subsequent improve-
ments have also been obtained from a more aggressive
treatment of ROP,26,27 the use of further laser sessions,
even when active avascular islets remain, and the appli-
cation of intravitreal bevacizumab.28 These measures have
“Oxygen with Love” and retinopathy of prematurity 401led to excellent rates of structural outcome, with only
4e5% adverse effects.7,28
The improvements made to the ROP program at our
hospital in the past 3 years have produced the results
described here. Aspects such as the lower incidence of
infection and sepsis, and improved infant nutrition, which
have no direct relationship with the OWL program, have
also helped to improve results in the treatment of ROP.
In conclusion, the actions implemented to improve pedi-
atric and ophthalmologic care have reduced the risk of unfa-
vorable structural outcomes in ROP by 84%, due particularly
to improvements in oxygen monitoring (the OWL program)
and the diode laser treatment for retinal ablation.29References
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